Joshua Milner, MD

Joshua Milner is a leader in the field of discovery and immunopathogenesis of genetic diseases that lead to allergic symptoms and immunologic disorders. Among the diseases has described PLAID—an immune disorder that leads to lifelong cold urticaria, the glycosylation disorder PGM3 deficiency, ERBIN mutation, CARD11 dominant negative mutations, STAT3 gain-of-function, Hereditary Alpha Tryptasemia Syndrome, IL-6 receptor deficiency, and others. His lab coined the term Primary Atopic Disorders, which refer to genetic diseases which cause allergies and allergic inflammation.

Dr. Milner's vision is to establish how genetic variation can help inform diagnosis and care of all p...